RecruitingNot ApplicableNCT07500116

NORA-HOME: An Ambulatory Multimodal Monitoring Model In Patients With Minor Stroke And Transient Ischemic Attacks

NORA-HOME. Efficiency And Safety An Ambulatory Multimodal Monitoring Model In Patients With Minor Stroke And Transient Ischemic Attacks


Sponsor

Hospital Universitari Vall d'Hebron Research Institute

Enrollment

250 participants

Start Date

Jan 29, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

In this project, we aim to validate a Home Hospitalization plan for patients with TIA or minor stroke. Our hypothesis is that our Multimodal Home Hospitalization program (NORAHOME) for patients with TIA and minor stroke is safe, reduces the complications associated with conventional hospitalization, and is more efficient than Standard Clinical Practice. To conduct the study, we require the voluntary participation of patients with TIA and minor strokes.


Eligibility

Inclusion Criteria5

  • Age \>18 years.
  • Availability of a smartphone for the patient or caregiver.
  • Family support and/or formal caregiver.
  • Clinical stability during the last 12 hours in the Emergency Department.
  • Signed informed consent by the patient and/or family member or legal representative.

Exclusion Criteria3

  • Severe stenosis or symptomatic arterial occlusion requiring admission for potential reperfusion and/or arterial revascularization treatments.
  • Patients with pre-existing neurological or psychiatric conditions that may interfere with or complicate follow-up and evaluations.
  • Clinical (terminal condition) or social (language barrier) impossibility to complete follow-up assessments.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERHome hospitalization

patients randomized to the treatment group (NORAHOME) to validate that our Home Hospitalization program for patients with TIA or minor stroke


Locations(1)

Vall Hebron University Hospital

Barcelona, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07500116


Related Trials